Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

University of California San Diego

Status and phase

Completed

Phase 4

Conditions

Hypertension

Prehypertension

Pulse Wave Velocity

24 Hour Blood Pressure

Gout

Treatments

Drug: Febuxostat

Study type

Interventional

Funder types

Other

Identifiers

NCT01472692

110806

Details and patient eligibility

About

High normal blood pressure, also called prehypertension, is a significant problem. High uric acid in the blood, the same thing that causes gout, may cause higher blood pressures. The investigators plan to monitor the effects of the drug febuxostat(trade name Uloric) on blood pressure and stiffness of the main blood vessels and see if lowering uric acid has any effect.

Enrollment

47 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Prehypertensive male and female subjects with SBP =120-140 mmHg or DBP =80-90 mmHg (as determined by seated office BP).
Plasma uric acid level ≥5 mg/dl
Ages 18-50
non-smokers
Subjects will need to remain in the San Diego area for the duration of the study and be accessible by telephone or email.

Exclusion criteria

no current smoking in the prior 6 months.
Any history of any serious medical conditions requiring close monitoring from physicians- such as liver impairment, chronic kidney disease, or diabetes mellitus. Participants not currently under the care of a physician for these conditions will be eligible for the study.
Any history of gout, hypertension, hypercholesterolemia, morbid obesity.
Any history of use xanthine oxidase inhibitors, antihypertensives, antiglycemic, and cholesterol lowering medications
any history of illicit drug use within the last 6 months